TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Pterostilbene, Sunitinib
Phytochemical Name Pterostilbene (PubChem CID: 5281727 )
Anticancer drug Name Sunitinib (PubChem CID: 5329102 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 365
Pair Name Pterostilbene, Sunitinib
Disease Info [ICD-11: 2B72] Gastric cancer Investigative
Biological Phenomena Induction-->Oxidative Stress
Gene Regulation Down-regulation Expression PDZD8 hsa118987
In Vitro Model TMK-1 Gastric adenocarcinoma Homo sapiens (Human) CVCL_4384
MKN74 Gastric tubular adenocarcinoma Homo sapiens (Human) CVCL_2791
In Vivo Model Subcutaneous tumor models were established by inoculating cancer cells (MKN74: 5×10⁶ per mouse, TMK-1: 1×107 per mouse) into the scapular subcutaneous tissues of nude mice on Day 0.
Result PDZD8 may be a newly discovered off-target for SUN, and that the combined use of PTE with SUN significantly promotes antitumor activity in gastric cancer cell lines. The combined use of SUN and PTE might be a new molecular-targeted therapy for gastric cancer.
03. Reference
No. Title Href
1 Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8. Int J Mol Sci. 2022 Apr 4;23(7):4002. doi: 10.3390/ijms23074002. Click
It has been 47857 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP